Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Osimertinib Tablets bulk supplier for pharma manufacturers

Osimertinib Tablets 40 mg, 80 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 40 mg, 80 mg

Reference Brands: Tagrisso (USA/EU)

Category: Oncology Cancer Care

Osimertinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) genes.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Osimertinib Tablets — third party manufacturing & bulk supply

Osimertinib Tablets 40 mg, 80 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Osimertinib Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Osimertinib Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Osimertinib Tablets →
Back to Listing

Frequently Asked Questions

Osimertinib Tablets is listed as Tablets in 40 mg, 80 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Osimertinib Tablets is referenced against Tagrisso (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Crizotinib Capsules

Strength:
200mg, 250mg

Form: Capsules

Reference Brands: Xalkori (US/EU)

View Details
Palbociclib Tablet

Strength:
75mg, 100mg, 125mg

Form: Tablets

Reference Brands:

View Details
Venetoclax Tablet

Strength:
50mg, 100mg

Form: Tablets

Reference Brands:

View Details
Ixazomib Capsule

Strength:
2.3mg, 3mg, 4mg

Form: Capsules

Reference Brands: Ninlaro (US/EU)

View Details
Vinorelbine

Strength:
Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg

Form: Intravenous Injection, Oral Capsule

Reference Brands: Navelbine® , Alocrest (US & EU)

View Details
Octreotide Acetate Pen

Strength:
25000 mcg, 7000 mcg

Form: injection (prefilled syringe)

Reference Brands: Bynfezia Pen (USA)

View Details
Doxorubicin Liposomal

Strength:
20 mg/10 mL (2 mg/mL), 50 mg/25 mL (2 mg/mL)

Form: Liposomal Injection (

Reference Brands: Doxil® , Caelyx® (EU & US)

View Details
Dacarbazine

Strength:
100 mg/vial, 200 mg/vial

Form: IV Injection

Reference Brands: DTIC-Dome®(EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.